FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40205311000001107: Orladeyo 150mg capsules (BioCryst Ireland Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2245081000001115 Orladeyo 150mg capsules (BioCryst Ireland Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2245091000001118 Orladeyo 150mg capsules (BioCryst Ireland Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Is a Berotralstat 150mg capsules true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Is a Orladeyo true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Berotralstat false Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has specific active ingredient Berotralstat dihydrochloride true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Orladeyo 150mg capsules (BioCryst Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Berotralstat true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Orladeyo 150mg capsules (BioCryst Ireland Ltd) 28 capsule 4 x 7 capsules Has AMP True Orladeyo 150mg capsules (BioCryst Ireland Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start